Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brequinar sodium

D V Cramer1

  • 1Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA 90211, USA.

Pediatric Nephrology (Berlin, Germany)
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Brequinar sodium effectively suppresses the immune system by disrupting cell proliferation, offering a new approach to prevent organ transplant rejection. Its combination with other immunosuppressants shows synergistic effects in preclinical studies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Subacute Study of Rats Fed Ground Beef Treated with Aqueous Chlorine - Anatomic Pathology.

Journal of food protection·2019
Same author

Specific and stable CTL tolerance induced by veto mechanism.

Immunology today·2014
Same author

Maturation of xenoantibody gene expression during the humoral immune response of rats to hamster xenografts.

Xenotransplantation·2001
Same author

Functional metabolic characteristics of intact pig livers during prolonged extracorporeal perfusion: potential for a unique biological liver-assist device.

Transplantation·2001
Same author

Dual cell seeding and the use of zymogen tissue plasminogen activator to improve cell retention on polytetrafluoroethylene grafts.

Journal of vascular surgery·2001
Same author

Characteristics of immunoglobulin gene usage of the xenoantibody binding to gal-alpha(1,3)gal target antigens in the gal knockout mouse.

Transplantation·2001
Same journal

Atypical renal phenotype with tubular proteinuria and hypercalciuria in siblings with nail-patella syndrome: evidence for a dual genetic diagnosis.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

Blood pressure control in pediatric hemodialysis: data from the SCOPE collaborative.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

Correlation between urinary soluble CD163 and endocapillary proliferation and fibrinoid necrosis in IgA vasculitis with nephritis.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

SGLT2i, anti-endothelin A and double endothelin and angiotensin inhibitors: a new future for chronic kidney disease in children.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

The role of urinary trehalase levels in the early diagnosis of acute kidney injury in dehydrated children.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

Neuron-specific enolase and brain-derived neurotrophic factor as developmental neurovascular markers in chronic kidney disease and kidney transplantation.

Pediatric nephrology (Berlin, Germany)·2026
See all related articles

Area of Science:

  • Immunology
  • Pharmacology
  • Transplantation

Background:

  • Organ graft rejection remains a significant challenge in transplantation.
  • Novel immunosuppressive agents are crucial for improving transplant outcomes.
  • Brequinar sodium represents a new class of immunosuppressants targeting pyrimidine biosynthesis.

Purpose of the Study:

  • To characterize the immunosuppressive activity of brequinar sodium.
  • To investigate the mechanism of action of brequinar sodium, focusing on pyrimidine biosynthesis and cell proliferation.
  • To evaluate the potential of brequinar sodium in combination therapy for preventing allograft and xenograft rejection.

Main Methods:

  • Preclinical and clinical characterization of brequinar sodium.
  • Assessment of its effects on T and B cell immune function.

Related Experiment Videos

  • Experimental studies combining brequinar sodium with cyclosporin or FK 506.

    • Main Results:

    • Brequinar sodium exhibits highly effective immunosuppressive activity.
    • The drug interferes with pyrimidine biosynthesis, leading to disrupted cell proliferation.
    • Combination therapy with cyclosporin or FK 506 demonstrated synergistic effects in preventing graft rejection.

    Conclusions:

    • Brequinar sodium is a potent immunosuppressant with a unique mechanism of action.
    • Its antiproliferative effects on immune cells offer potential for transplant rejection prevention.
    • Further clinical studies are warranted to evaluate brequinar sodium in transplantation.